Literature DB >> 12926848

Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales.

A Riazi1, J C Hobart, D L Lamping, R Fitzpatrick, A J Thompson.   

Abstract

The selection of measures of quality of life used in clinical trials of multiple sclerosis (MS) should be evidence-based. Head-to-head comparison of measures facilitates the selection of measures. The aim of the study was to compare the psychometric properties of the physical and psychological dimensions in three measures of quality of life to aid choice of the most appropriate scale for use in clinical trials of MS. One hundred and twenty-one people with MS (rehabilitation = 57; steroids = 64) completed a selection of health measures before and after treatment. The psychometric properties of three measures of physical function (MSIS-29 physical, SF-36 physical functioning, FAMS mobility) and three measures of psychological function (MSIS-29 psychological, SF-36 mental health, FAMS emotional well-being) were compared by examining data quality, scaling assumptions, acceptability, reliability, validity and responsiveness. Physical (0.63-0.71) and psychological (0.70-0.75) scales were substantially correlated indicating they measure related constructs. The MSIS-29 physical and psychological scales satisfied all criteria for internal consistency reliability (physical = 0.91; psychological = 0.89) and validity. The SF-36 physical scale had a notable floor effect (20%). The FAMS mobility scale had lower reliability (alpha = 0.78) compared to other measures. The MSIS-29 physical (effect size = 0.91) and psychological (effect size = 0.62) scales were the most responsive. In these three samples, the MSIS-29 had better measurement properties for combined physical and psychological health than the SF-36 and the FAMS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926848     DOI: 10.1191/1352458503ms929oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  18 in total

1.  Change in the Health-Related Quality of Life of Multiple Sclerosis Patients over 5 Years.

Authors:  Wonita Janzen; Karen V L Turpin; Sharon A Warren; Ruth Ann Marrie; Kenneth G Warren
Journal:  Int J MS Care       Date:  2013

2.  Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use.

Authors:  F A H van der Linden; J J Kragt; M Klein; H M van der Ploeg; C H Polman; B M J Uitdehaag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical).

Authors:  Lisa Costelloe; Killian O'Rourke; Hugh Kearney; Christopher McGuigan; Lisa Gribbin; Marguerite Duggan; Leslie Daly; Niall Tubridy; Michael Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-01       Impact factor: 10.154

4.  How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales.

Authors:  J C Hobart; A Riazi; D L Lamping; R Fitzpatrick; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

Review 5.  The effect of deep brain stimulation on quality of life in movement disorders.

Authors:  A Diamond; J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

6.  Body Esteem Among Women with Multiple Sclerosis and its Relationship with Demographic, Clinical and Socio-Psychological Factors.

Authors:  M Wilski; T Tasiemski; A Dąbrowski
Journal:  Int J Behav Med       Date:  2016-06

7.  The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies.

Authors:  Maciej Wilski; Waldemar Brola; Magdalena Łuniewska; Maciej Tomczak
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

8.  Rasch analysis of the Multiple Sclerosis Impact Scale MSIS-29.

Authors:  Melina Ramp; Fary Khan; Rose Anne Misajon; Julie F Pallant
Journal:  Health Qual Life Outcomes       Date:  2009-06-22       Impact factor: 3.186

9.  Getting the balance right: a randomised controlled trial of physiotherapy and Exercise Interventions for ambulatory people with multiple sclerosis.

Authors:  Susan Coote; Maria Garrett; Neasa Hogan; Aidan Larkin; Jean Saunders
Journal:  BMC Neurol       Date:  2009-07-16       Impact factor: 2.474

10.  Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge.

Authors:  Karine Baumstarck; Laurent Boyer; Mohamed Boucekine; Pierre Michel; Jean Pelletier; Pascal Auquier
Journal:  Mult Scler Int       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.